MedPath

Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center logo
🇺🇸United States
Ownership
Private
Established
1884-01-01
Employees
10K
Market Cap
-
Website
http://www.mskcc.org

Study of CAR-T Therapy in Older Patients

Active, not recruiting
Conditions
High-grade B-cell Lymphoma
DLBCL NOS
Multiple Myeloma
Lymphoma
Refractory B-Cell Lymphoma
Lymphoma, B-Cell
Interventions
Behavioral: Activities of Daily Living/ADLs
Behavioral: Instrumental Activity of Daily Living
Behavioral: Timed Up and Go
Behavioral: Cognition
Behavioral: Geriatric Depression Scale
Behavioral: Social Support
Behavioral: Brief Test of Attention
Behavioral: Trail Making Test
Behavioral: Controlled Oral Word Association Test
Behavioral: Hopkins Verbal Learning Test-Revised
Other: Blood draw
First Posted Date
2020-03-09
Last Posted Date
2024-11-07
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
141
Registration Number
NCT04300998
Locations
🇺🇸

Memorial Sloan Kettering Cancer Center, New York, New York, United States

A Study of the Body's Response to Exercise and a Plant-Based Diet in Overweight Postmenopausal Women With Breast Cancer

Phase 2
Active, not recruiting
Conditions
Breast Cancer
Primary Hormone Receptor Positive Breast Cancer
Interventions
Other: Exercise Treatment
Other: Physical activity
Other: Nutrition counseling
Other: Plant-Based Diet
Other: Replication Exercise Test
First Posted Date
2020-03-06
Last Posted Date
2024-08-02
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
43
Registration Number
NCT04298086
Locations
🇺🇸

Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States

🇺🇸

Memorial Sloan Kettering Commack (Limited Protocol Activities), Commack, New York, United States

🇺🇸

Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States

and more 4 locations

Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease

Recruiting
Conditions
Endometrioid Adenocarcinoma
Endometrial Cancer
Endometrial Cancer Stage I
Interventions
Other: Physical exam
First Posted Date
2020-03-02
Last Posted Date
2024-05-24
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
1400
Registration Number
NCT04291612
Locations
🇺🇸

Mayo Clinic (Data Collection and Data Analysis), Rochester, Minnesota, United States

🇺🇸

University of Miami (Data Collection Only), Miami, Florida, United States

🇺🇸

Miami Cancer Institute Baptist Health South Florida, Miami, Florida, United States

and more 16 locations

Dose Reduction of Postoperative Radiation for Soft Tissue Sarcoma of the Arms and Legs

Phase 2
Recruiting
Conditions
Soft Tissue Sarcoma
Interventions
Radiation: Intensity-modulated radiation therapy (IMRT)
First Posted Date
2020-02-28
Last Posted Date
2024-03-04
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
60
Registration Number
NCT04288375
Locations
🇺🇸

Memorial Sloan Kettering Nassau (All protocol activities), Uniondale, New York, United States

🇺🇸

Memorial Sloan Kettering Westchester (All protocol activities), Harrison, New York, United States

🇺🇸

Memorial Sloan Kettering Basking Ridge (All protocol activities), Basking Ridge, New Jersey, United States

and more 4 locations

Observing People With Desmoid-Type Fibromatosis

Recruiting
Conditions
Desmoid Fibromatosis
Interventions
Diagnostic Test: Cross-sectional imaging
First Posted Date
2020-02-24
Last Posted Date
2024-03-04
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
100
Registration Number
NCT04281381
Locations
🇺🇸

Memorial Sloan Kettering Cancer Center, New York, New York, United States

AG-120 in People With IDH1 Mutant Chondrosarcoma

Phase 2
Active, not recruiting
Conditions
Chondrosarcoma, Grade 3
IDH1 Gene Mutation
Chondrosarcoma
Chondrosarcoma, Grade 2
Interventions
Drug: AG-120
First Posted Date
2020-02-20
Last Posted Date
2024-10-11
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
6
Registration Number
NCT04278781
Locations
🇺🇸

Johns Hopkins Hospital (Data Collection Only), Baltimore, Maryland, United States

🇺🇸

Columbia University (Specimen Analysis Only), New York, New York, United States

🇺🇸

Memorial Sloan Kettering Cancer Center, New York, New York, United States

and more 2 locations

Game-Based Physical Activity in Childhood Cancer Survivors

Not Applicable
Active, not recruiting
Conditions
Survivors of Childhood Cancer
Interventions
Other: Fitbit Inspire HR
Other: Questionaires
First Posted Date
2020-02-12
Last Posted Date
2024-03-08
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
48
Registration Number
NCT04266080
Locations
🇺🇸

Memorial Sloan Kettering Cancer Center, New York, New York, United States

Study of Abiraterone Acetate or Enzalutamide, Atezolizumab, GnRH Analog and Radiation Therapy in Men With Newly Diagnosed Hormone-sensitive Prostate Cancer

Phase 2
Active, not recruiting
Conditions
Metastatic Prostate Cancer
Interventions
Drug: Atezolizumab
Drug: Abiraterone
Drug: Prednisone
Drug: GnRH analog
Radiation: Stereotactic Body Radiotherapy (SBRT)
Drug: Enzalutamide
Other: Follow up
First Posted Date
2020-02-10
Last Posted Date
2024-02-09
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
28
Registration Number
NCT04262154
Locations
🇺🇸

Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale, New York, United States

🇺🇸

Memorial Sloan Kettering Cancer Commack (Limited Protocol Activities), Commack, New York, United States

🇺🇸

Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison, New York, United States

and more 5 locations

Study of DCC-3014 in Combination With Avelumab in Patients With Advanced or Metastatic Sarcomas

Phase 1
Active, not recruiting
Conditions
Sarcoma
Advanced Sarcoma
High Grade Sarcoma
Leiomyosarcoma
Undifferentiated Pleomorphic Sarcoma
Myxofibrosarcoma
Dedifferentiated Liposarcoma
Interventions
Drug: DCC-3014
Drug: Avelumab
First Posted Date
2020-01-27
Last Posted Date
2024-04-25
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
32
Registration Number
NCT04242238
Locations
🇺🇸

Memorial Sloan Kettering Cancer Center, New York, New York, United States

Does Immediate Lymphatic Reconstruction Decrease the Risk of Lymphedema After Axillary Lymph Node Dissection

Phase 3
Active, not recruiting
Conditions
Breast Cancer Lymphedema
Interventions
Procedure: Axillary Lymph Node Dissection without Immediate Lymphatic Reconstruction
Procedure: Axillary Lymph Node Dissection with Immediate Lymphatic Reconstruction
Other: quality-of-life questionnaires
Other: measured by arm volume
First Posted Date
2020-01-27
Last Posted Date
2024-11-07
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
180
Registration Number
NCT04241341
Locations
🇺🇸

Memorial Sloan Kettering Monmouth (Consent Only), Middletown, New Jersey, United States

🇺🇸

Memorial Sloan Kettering Bergen (Consent Only), Montvale, New Jersey, United States

🇺🇸

Memorial Sloan Kettering Basking Ridge (Consent and Followup), Basking Ridge, New Jersey, United States

and more 4 locations
© Copyright 2025. All Rights Reserved by MedPath